Guardian Pharma · Transparency
Editorial Standards & Medical Information Policy
How our health and medicine articles are researched, written, checked, updated and presented to readers.
Important information about medical review
Guardian Pharma’s current modafinil articles are published under the Guardian Pharma Editorial Team. Guardian Pharma has designated Andrew Ng, Superintendent Pharmacist (GPhC registration number 2036332), as the intended clinical reviewer for the five Modafinil educational articles. Mr Ng has agreed to undertake this review. The review is not yet complete, so the articles must continue to be labelled “medical review pending” and must not be described as medically reviewed until he has assessed and approved each article. His name and professional designation are published with his agreement.
Who writes our content?
Our educational articles are prepared and maintained by the Guardian Pharma Editorial Team. The team researches publicly available clinical literature, official medicine information and guidance from recognised regulatory or public-health bodies. The editorial author profile describes the publishing team; it does not claim that the team members are doctors, pharmacists or other regulated healthcare professionals.
Medical review and reviewer credentials
Where an article is independently medically reviewed, the reviewer should be identified by their full name, professional designation, relevant area of expertise and appropriate registration or professional-verification details where applicable. Reviewer approval must be obtained before their name or credentials are published. A reviewer’s role is to assess clinical accuracy, balance, safety information and the suitability of cited sources. Editorial review by the publisher is not the same as independent medical review.
Until a reviewer has been appointed and has approved the article, the page will state that independent medical review is pending. We will not create fictional reviewer identities, qualifications, registration numbers or review dates.
How we research and cite information
- We prioritise current UK Summary of Product Characteristics (SmPCs), patient information leaflets and Medicines and Healthcare products Regulatory Agency (MHRA) safety communications for UK medicine information.
- We use peer-reviewed research and systematic reviews where relevant, while explaining limitations, uncertainty and differences between research findings and licensed indications.
- We distinguish UK-authorised indications from off-label use, experimental research and information from other countries.
- We link to primary or authoritative sources so readers can check the underlying information.
- We do not present general educational content as an individual diagnosis, prescription or treatment recommendation.
Safety, risks and medicine interactions
Medicine articles should describe material warnings and relevant adverse reactions in proportion to the evidence. They should not encourage readers to start, stop, change or combine prescription medicines without advice from the prescriber or another appropriately qualified healthcare professional. Readers should consult the product information for the exact medicine and formulation they have been prescribed.
Updates and corrections
We aim to review medicine-related articles when relevant regulatory advice, product information or important evidence changes. Pages should display a meaningful review or update date when a substantive review has taken place. If an error is identified, we will assess it and correct the page as appropriate. A date change alone does not mean that a medical professional has reviewed an article.
Editorial independence and commercial transparency
Commercial interests must not determine the interpretation of clinical evidence or suppress important safety information. Product or service information, where present, should be distinguishable from independent educational material. Readers should be able to identify the publisher and contact Guardian Pharma with editorial questions or correction requests.
Contact the editorial team
For editorial corrections or questions about this policy, contact [email protected].
Guardian Pharma · 448 Kingsland Road, Dalston, London, E8 4AE, United Kingdom · guardianpharma.co.uk